Fabienne Z Gaugaz
Overview
Explore the profile of Fabienne Z Gaugaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolz C, Gaugaz F, Handin N, Schaeffeler E, Tremmel R, Winter S, et al.
Br J Pharmacol
. 2024 Aug;
181(22):4593-4609.
PMID: 39096023
Background And Purpose: The ATP-dependent biliary efflux transporter ABCC2, also known as multidrug resistance protein 2 (MRP2), is essential for the cellular disposition and detoxification of various xenobiotics including drugs...
2.
Tremmel R, Nies A, van Eijck B, Handin N, Haag M, Winter S, et al.
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806468
The hepatic Na-taurocholate cotransporting polypeptide NTCP/ is important for the uptake of bile salts and selected drugs. Its inhibition results in increased systemic bile salt concentrations. NTCP is also the...
3.
Skogh A, Lesniak A, Skold C, Karlgren M, Gaugaz F, Svensson R, et al.
Bioorg Med Chem Lett
. 2018 Jun;
28(14):2446-2450.
PMID: 29929882
The dipeptide amide H-Phe-Phe-NH (1) that previously was identified as a ligand for the substance P 1-7 (SP) binding site exerts intriguing results in animal models of neuropathic pain after...
4.
Skogh A, Lesniak A, Gaugaz F, Svensson R, Lindeberg G, Fransson R, et al.
Eur J Pharm Sci
. 2017 Sep;
109:533-540.
PMID: 28887235
Substance P 1-7 (SP, Arg-Pro-Lys-Pro-Gln-Gln-Phe) is the major bioactive metabolite formed after proteolytic degradation of the tachykinin substance P (SP). This heptapeptide often opposes the effects of the mother peptide....
5.
Wegler C, Gaugaz F, Andersson T, Wisniewski J, Busch D, Groer C, et al.
Mol Pharm
. 2017 Aug;
14(9):3142-3151.
PMID: 28767254
Many different methods are used for mass-spectrometry-based protein quantification in pharmacokinetics and systems pharmacology. It has not been established to what extent the results from these various methods are comparable....
6.
Skogh A, Lesniak A, Gaugaz F, Svensson R, Lindeberg G, Fransson R, et al.
Eur J Pharm Sci
. 2017 Jun;
106:345-351.
PMID: 28587787
The heptapeptide SP (1, Arg-Pro-Lys-Pro-Gln-Gln-Phe) is the major bioactive metabolite formed after proteolytic processing of the neuropeptide substance P (SP, Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH). The heptapeptide 1 frequently exhibits opposite effects to those...
7.
Gad H, Koolmeister T, Jemth A, Eshtad S, Jacques S, Strom C, et al.
Nature
. 2017 Apr;
544(7651):508.
PMID: 28447629
No abstract available.
8.
Simoff I, Karlgren M, Backlund M, Lindstrom A, Gaugaz F, Matsson P, et al.
J Pharm Sci
. 2016 Feb;
105(2):1017-1021.
PMID: 26869442
Madin-Darby canine kidney II cells transfected with one or several transport proteins are commonly used models to study drug transport. In these cells, however, endogenous transporters such as canine Mdr1/P-glycoprotein...
9.
Wisniewski J, Gaugaz F
Anal Chem
. 2015 Apr;
87(8):4110-6.
PMID: 25837572
The determination of total protein content is one of the most frequent analytical tasks in biochemistry and molecular biology. Here we evaluate measurements of tryptophan fluorescence (WF) for total protein...
10.
Gaugaz F, Redondo-Horcajo M, Barasoain I, Fernando Diaz J, Cobos-Correa A, Kaufmann M, et al.
ChemMedChem
. 2014 Jul;
9(10):2227-32.
PMID: 25045073
Two cis-12,13-cyclopropyl-epothilone B variants have been synthesized, differing only in the configuration of the stereocenters at C12 and C13. The syntheses were based on a common allylic alcohol intermediate that...